照护现场血糖测试市场规模、份额、成长分析，按类型、按应用、按最终用户、按地区 - 行业预测，2025-2032 年

2023 年照护现场血糖测试市场规模预计为 34.4 亿美元，从 2024 年的 35.8 亿美元增长到 2032 年的 49.8 亿美元，预测期间（2025-2032 年）预计将以 4.2% 的复合年增长率增长。

在糖尿病盛行率上升以及对便利性即时血糖监测解决方案的需求的推动下，全球照护现场血糖检测市场正在显着成长。可携式测试设备使医疗保健专业人员和患者能够在护理点快速评估血糖值，从而促进更好的疾病管理并改善患者的治疗结果。技术进步和人们对常规血糖监测重要性的认识不断提高，支持了市场的扩张。但需要注意设备价格、确保检测精度等问题。特别是，创新机会比比皆是，包括新的生物感测器技术以及与数位健康平台的集成，这最终将简化护理并改善糖尿病管理，并为世界各地的患者提供帮助，这是一个旨在降低医疗保健成本的市场。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

照护现场血糖测试市场规模：按类型

• 市场概况
• 穿刺装置和条带
• 血糖值仪

照护现场血糖检测市场规模：依应用分类

• 市场概况
• 1型糖尿病
• 2型糖尿病

照护现场

• 市场概况
• 医院和诊所
• 家庭护理设置
• 其他的

照护现场血糖检测市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Abbott Laboratories（USA）
• Roche Holding AG（Switzerland）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Dexcom, Inc.（USA）
• Medtronic plc（Ireland）
• LifeScan, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• ACON Laboratories, Inc.（USA）
• Nova Biomedical Corporation（USA）
• ARKRAY, Inc.（Japan）
• Trividia Health, Inc.（USA）
• PTS Diagnostics（USA）
• Nipro Corporation（Japan）
• Ypsomed Holding AG（Switzerland）
• Sanofi SA（France）
• EKF Diagnostics Holdings plc（UK）
• Prodigy Diabetes Care, LLC（USA）
• Bayer AG（Germany）
• Danaher Corporation（USA）
• Platinum Equity Advisors, LLC（USA）

结论和建议

Point-of-care Glucose Testing Market size was valued at USD 3.44 Billion in 2023 and is poised to grow from USD 3.58 Billion in 2024 to USD 4.98 Billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global point-of-care glucose testing market is experiencing substantial growth, fueled by the rising prevalence of diabetes and the demand for convenient, immediate glucose monitoring solutions. Portable testing devices enable healthcare professionals and patients to rapidly assess blood sugar levels at the point of care, promoting better disease management and improved patient outcomes. The market's expansion is supported by advancements in technology and heightened awareness of the importance of routine glucose monitoring. However, challenges like device affordability and ensuring test accuracy need attention. Opportunities for innovation abound, particularly with emerging biosensor technologies and integration with digital health platforms, positioning the market to enhance diabetes management and empower patients worldwide, ultimately aiming to streamline care and reduce healthcare costs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Point-Of-Care Glucose Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Point-Of-Care Glucose Testing Market Segmental Analysis

Global Point-Of-Care Glucose Testing Market is segmented by type, application, end user and region. Based on type, the market is segmented into lancing devices and strips and blood-glucose meter. Based on application, the market is segmented into type-1 diabetes and type-2 diabetes. Based on end user, the market is segmented into hospitals and clinics, home care settings and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Point-Of-Care Glucose Testing Market

One of the primary catalysts for growth in the point-of-care glucose testing market is the rising prevalence of diabetes worldwide. As reported by the International Diabetes Federation, the number of adults diagnosed with diabetes is projected to soar to 700 million by 2045. This alarming increase highlights the critical need for consistent glucose monitoring to manage the condition effectively. Consequently, the growing population of diabetes patients significantly boosts the demand for point-of-care testing devices, which offer timely and convenient monitoring solutions. This trend underscores the vital role that these testing systems play in improving patient care and health outcomes in diabetes management.

Restraints in the Point-Of-Care Glucose Testing Market

One significant restraint on the Point-of-Care Glucose Testing market is the high cost associated with testing devices and related consumables. This financial barrier can impede market expansion, especially in developing areas where healthcare resources are scarce, and disposable incomes are lower. The elevated prices of these testing devices may deter extensive adoption, particularly within low-income populations and healthcare institutions operating under budget limitations. As a result, the affordability issue poses a challenge to the accessibility of point-of-care glucose testing, thereby affecting its utilization and potential growth in various regions where economic constraints exist.

Market Trends of the Point-Of-Care Glucose Testing Market

The Point-Of-Care Glucose Testing market is increasingly characterized by the integration of testing devices with digital health platforms and electronic health records. This trend, gaining momentum through 2022 and beyond, facilitates seamless data transfer and real-time monitoring of glucose levels, enhancing patient engagement in diabetes management. By empowering individuals with actionable insights and enabling healthcare professionals to access comprehensive patient data, this integration supports informed decision-making and personalized treatment plans. As technology continues to advance, the demand for interconnected health solutions is expected to grow, driving innovations in the Point-Of-Care Glucose Testing sector and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Point-Of-Care Glucose Testing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Lancing Devices and Strips
• Blood-Glucose Meter

Global Point-Of-Care Glucose Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Type-1 Diabetes
• Type-2 Diabetes

Global Point-Of-Care Glucose Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Home Care Settings
• Others

Global Point-Of-Care Glucose Testing Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prodigy Diabetes Care, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Platinum Equity Advisors, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations